The Relationship of Volume of Clinical Studies and the Sales Volume of Prescription Drugs after NHIA Reimbursement
碩士 === 國立臺北大學 === 企業管理學系 === 105 === The purpose of this research is to investigate the relationship between the volume of clinical studies and the volume of sales of specialty drugs and common chronic diseases drugs after NHIA (National Health Insurance Administration) reimbursement. For specialty...
Main Authors: | Huang, Wei-Yi, 黃偉毅 |
---|---|
Other Authors: | Shieh, Jiin-Tarng |
Format: | Others |
Language: | zh-TW |
Published: |
2017
|
Online Access: | http://ndltd.ncl.edu.tw/handle/6uazn8 |
Similar Items
-
Strategy for NHIA Drug Expenditure Target:A Case Study of Statin drug
by: Chen, Chien Hong, et al.
Published: (2016) -
The speed of adoption of new drugs and prescription volume after the amendments in reimbursement coverage: the case of non-vitamin K antagonist oral anticoagulants in South Korea
by: Kyung-Bok Son
Published: (2020-05-01) -
Existing data sources for clinical epidemiology: The Danish National Database of Reimbursed Prescriptions
by: Johannesdottir SA, et al.
Published: (2012-11-01) -
Effects of Reimbursement Policy Change to Zolpidem Prescription Pattern
by: Lung Chiu-Lan, et al.
Published: (2015) -
Sales Momentum and Trading Volume
by: Li-Fei Lin, et al.
Published: (2014)